Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Misoprostol vaginal insert - Ferring Pharmaceuticals

Next Previous
X
Search
Drug Profile

Misoprostol vaginal insert - Ferring Pharmaceuticals

Alternative Names: Misodel; Misopess; Misoprostol CR insert; MVI 100; Mysodelle; Myspess; XP 16J

Latest Information Update: 09 Dec 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cytokine PharmaSciences
  • Developer Cytokine PharmaSciences; Ferring Pharmaceuticals
  • Class Abortifacients; Antiulcers; Oxytocics; Prostaglandins
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Labour induction

Most Recent Events

  • 29 Jul 2019 Misoprostol vaginal insert is not yet available for Labour induction in Bulgaria, Cyprus, Estonia, France, Greece, Hungary, Iceland, Latvia, Lithuania, Luxembourg, Malta, Portugal, Romania, Slovakia, Slovenia, Spain
  • 08 May 2019 Launched for Labour induction in Poland prior May 2019 (Vaginal)
  • 09 May 2016 Launched for Labour induction in Israel (Vaginal) before May 2016

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top